Covid-19: Clinical Trials to Start on Colchicine by Hannah Joy on June 14, 2021 at 1:47 PM
Colchicine drug is gonna undergo a two-arm phase-II clinical trial by the Council of Scientific and Industrial Research (CSIR) to assess the safety and efficacy of the drug in treating Covid-19.
Colchicine is used for treating gout and related inflammatory conditions. The drug is expected to be an important therapeutic intervention for Covid patients with cardiac co-morbidities.
A number of global studies have confirmed now that cardiac complications during course of Covid-19 infections and post-Covid syndrome are leading to loss of many lives, and it is essential to look for new or repurposed drugs.
CSIR, Laxai Life Sciences to undertake trials on COVID-19 patients with Colchicine biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
New Delhi: Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd. Hyderabad, have been given the regulatory approval by DCGI to undertake a two-arm phase-II clinical trial to assess the safety and efficacy of the dr
The Council of Scientific and Industrial Research (CSIR) will undertake a two-arm phase-II clinical trial to assess the safety and efficacy of the drug Colchicine for the treatment of Covid-19 patients.Colchicine is used for treating gout and .
The Drugs Controller General of India has approved the Phase-II trial of Colchicine, which can help Covid-19 patients with co-morbidities related to heart and also for their faster recovery.